Biotech Senhwa Biosciences receives US FDA Study May Proceed letter for the Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors August 7, 2024
Biotech Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance August 7, 2024
Biotech IDEAYA Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update August 6, 2024
Biotech Bispecific Antibodies For Cancer Market size is set to grow by USD 314.3 million from 2024-2028, Increasing prevalence of cancer to boost the market growth, Technavio August 6, 2024
Biotech Regenerative Medicine Market to Reach $531.7 Billion, Globally, by 2033 at 32.4% CAGR: Allied Market Research August 6, 2024
Biotech First patient enrollment in the U.S. – A milestone for the global multi-center phase Ⅲ clinical trial of telitacicept for myasthenia gravis August 6, 2024
Biotech Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Ocular Surgery Relief and Recovery August 5, 2024
Biotech Invitation to the presentation of Calliditas´s interim report January – June 2024 August 5, 2024
Search
Biotech
August 7, 2024
August 7, 2024
August 7, 2024
August 7, 2024
August 6, 2024
August 6, 2024
August 6, 2024
August 6, 2024
August 5, 2024
August 5, 2024
